Immunopathogenesis of multiple sclerosis: concepts and controversies

被引:22
作者
Holmoy, T. [1 ]
机构
[1] Natl Hosp Norway, Inst Immunol, Radiumhosp, Ctr Med, N-0027 Oslo, Norway
[2] Univ Oslo, Oslo, Norway
[3] Ullevaal Univ Hosp, Dept Neurol, Oslo, Norway
来源
ACTA NEUROLOGICA SCANDINAVICA | 2007年 / 115卷
关键词
multiple sclerosis; immunology; neurobiology; neuroimmunology; infections;
D O I
10.1111/j.1600-0404.2007.00845.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Hundred and fifty years after the discovery of multiple sclerosis (MS), neither the etiology nor the mechanism of disease is fully charted, and current treatment has only modest effect. The conceptual understanding of MS rests on the animal model experimental autoimmune encephalomyelitis (EAE). Based on 70 years experience with EAE, it is widely believed that MS is an inflammatory attack on myelin and neurons orchestrated by myelin specific T cells. However, evidence supporting a key role for myelin specific T cells in MS is weak, the model fails to explain how immune self-tolerance is broken, and the peculiar B cell response of MS is poorly reflected in EAE. The pathogenesis of MS should therefore be studied in tissue samples and cells from MS patients, as close to the diseased organ as possible. Studies on lymphocytes from CSF of MS patients suggest that viral infections may be involved in T cell activation, and that intrinsic collaboration between T and B cells could sustain the immune response. These observations could explain the perpetuating immune response in MS in the absence of an overt antigen.
引用
收藏
页码:39 / 45
页数:7
相关论文
共 33 条
[1]   Transduced bone marrow-derived cells target brain tumors and express transgene [J].
Barnett, FH ;
Scheppke, EL ;
Moreno, SK ;
Uusitalo-Jarvinen, H ;
Yamanouchi, J ;
Shattil, S ;
Friedlander, M .
NEUROSURGERY, 2004, 55 (02) :468-468
[2]   Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand [J].
Bielekova, B ;
Goodwin, B ;
Richert, N ;
Cortese, I ;
Kondo, T ;
Afshar, G ;
Gran, B ;
Eaton, J ;
Antel, J ;
Frank, JA ;
McFarland, HF ;
Martin, R .
NATURE MEDICINE, 2000, 6 (10) :1167-1175
[3]   Grey matter pathology in multiple sclerosis [J].
Bö, L ;
Geurts, JJG ;
Mörk, SJ ;
van der Valk, P .
ACTA NEUROLOGICA SCANDINAVICA, 2006, 113 :48-50
[4]   IDIOTOPE-SPECIFIC T-CELL CLONES THAT RECOGNIZE SYNGENEIC IMMUNOGLOBULIN FRAGMENTS IN THE CONTEXT OF CLASS-II MOLECULES [J].
BOGEN, B ;
MALISSEN, B ;
HAAS, W .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (11) :1373-1378
[5]   The window of therapeutic opportunity in multiple sclerosis [J].
Coles, AJ ;
Cox, A ;
Le Page, E ;
Jones, J ;
Trip, SA ;
Deans, J ;
Seaman, S ;
Miller, DH ;
Hale, G ;
Waldmann, H ;
Compston, DA .
JOURNAL OF NEUROLOGY, 2006, 253 (01) :98-108
[6]   The basis for treatment in multiple sclerosis [J].
Compston, A .
ACTA NEUROLOGICA SCANDINAVICA, 2006, 113 :41-47
[7]   Infectious causes of multiple sclerosis [J].
Gilden, DH .
LANCET NEUROLOGY, 2005, 4 (03) :195-202
[8]   Infectious causes of multiple sclerosis [J].
Giovannoni, Gavin ;
Cutter, Gary R. .
LANCET NEUROLOGY, 2006, 5 (10) :887-889
[9]   Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research [J].
Gold, Ralf ;
Linington, Christopher ;
Lassmann, Hans .
BRAIN, 2006, 129 :1953-1971
[10]   Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells [J].
Holmoy, T ;
Fredriksen, AB ;
Thompson, KM ;
Hestvik, ALK ;
Bogen, B ;
Vartdal, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (06) :1786-1794